Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion

PURPOSETo report our experience with the delivery of passively scattered proton therapy in the management of nonmelanoma skin cancers with clinical perineural invasion. MATERIALS AND METHODSWe reviewed the medical records of patients who received definitive or postoperative proton therapy for nonmel...

Full description

Saved in:
Bibliographic Details
Published in:International journal of particle therapy 2021-06, Vol.8 (1), p.285-293
Main Authors: Bryant, Curtis M., Dagan, Roi, Holtzman, Adam L., Fernandes, Rui, Bunnell, Anthony, Mendenhall, William M.
Format: Article
Language:English
Subjects:
Clinical
particle therapy
prostate cancer
proton therapy
radiation therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PURPOSETo report our experience with the delivery of passively scattered proton therapy in the management of nonmelanoma skin cancers with clinical perineural invasion. MATERIALS AND METHODSWe reviewed the medical records of patients who received definitive or postoperative proton therapy for nonmelanoma skin cancer with clinical perineural invasion at our institution and updated patient follow-up when possible. All patients were treated with curative intent with or without the delivery of concurrent systemic therapy. We report disease control rates and the rates of late toxicity among this cohort. RESULTSTwenty-six patients treated between 2008 and 2017 were included in the analysis. Following proton therapy, the 3-year overall, cause-specific, and disease-free survival rates were 59%, 73%, and 60%, respectively. The 3-year local control, local regional control, and distant metastasis-free survival rates were 80%, 65%, and 96%, respectively. On univariate analysis, surgical resection before radiation therapy significantly improved local regional control rates at 3 years (55% versus 86%; P = .04). Grade 3+ late toxicities occurred in 13 patients (50%) and the most common toxicities included grade 3+ keratitis of the ipsilateral eye, which occurred in 4 patients (15%) and grade 3+ brain necrosis in 4 patients (15%). CONCLUSIONProton therapy is effective in the management of nonmelanoma skin cancer with clinical perineural invasion. Although disease control and complication rates compare favorably to those previously published for photon-based radiation therapy, the risk for late toxicity is significant and patients should be appropriately counseled.
ISSN:2331-5180
2331-5180
DOI:10.14338/IJPT-20-00062.1